Magyar Belgyógyász Társaság V. Magyar Kardiovaszkuláris Konszenzus Konferencia (Budapest, 2011.11.25.)
Rendezvény kezdete: 2011.11.25.Rendezvény vége: 2011.11.25. Szakterület(ek): Belgyógyászat, Hipertónia, Kardiológia
Tudományos információ: Dr. Pados Gyula, c. egyetemi docens Munkahely neve: Főv. Önk. Szent Imre Kórház, Lipidológiai profil Címe: 1115 Budapest, Tétényi út 12-16. Tel: 06 (1) 464-8721 E-mail: lipidprofil@szentimrekorhaz.hu Szervező: Magyar Orvostársaságok és Egyesületek Szövetsége (MOTESZ) Címe: 1051 Budapest, Nádor u. 36. Tel: 06 (1) 312-3807 Fax: 06 (1) 383-7918 E-mail: szalma.marta@motesz.hu Helyszín: 1143 Budapest, Stefánia út 34-36., Stefánia Palota A rendezvény Web oldala: http://www.motesz.hu A konferencián való részvétel térítésmentes.
A terem kapacitása korlátozott, ezért a jelentkezéseket a beérkezések sorrendjében regisztráljuk.
Jelentkezési határidő: 2011. október 24.
A program letölthető a kapcsolódó dokumentumok alól.Kapcsolódó dokumentumok (1)
Magyar Tüdőgyógyász Társaság World Allergy Congress 2005
Rendezvény kezdete: 2005.06.26.Rendezvény vége: 2005.07.01. Munkahely neve: Congrex Sweden AB Címe: Karlavägen 108 P.O. Box 5619 SE-114 86 Stockholm, Sweden Tel: +46-8-459 66 00 Fax: +46-8-661 91 25 E-mail: wac2005@congrex.se Helyszín: Munich Integrated basic and clinical themes will include current topics in immunology as well as mechanisms, prevention, diagnostics and treatment of diseases like asthma, rhinoconjunctivitis, sinusitis, atopic eczema, urticaria, drug reactions, contact dermatitis, anaphylaxis, autoimmune diseases and immunodeficiency , both in adults and children. For more information click on the website: www.congrex.com/wac2005
Magyar Tüdőgyógyász Társaság World Allergy Congress 2005
Rendezvény kezdete: 2005.06.26.Rendezvény vége: 2005.07.01. Munkahely neve: Congrex Sweden AB Címe: Karlavägen 108 P.O. Box 5619 SE-114 86 Stockholm, Sweden Tel: +46-8-459 66 00 Fax: +46-8-661 91 25 E-mail: wac2005@congrex.se Helyszín: Munich Integrated basic and clinical themes will include current topics in immunology as well as mechanisms, prevention, diagnostics and treatment of diseases like asthma, rhinoconjunctivitis, sinusitis, atopic eczema, urticaria, drug reactions, contact dermatitis, anaphylaxis, autoimmune diseases and immunodeficiency , both in adults and children. For more information click on the website: www.congrex.com/wac2005
Magyar Tüdőgyógyász Társaság World Allergy Congress 2005
Rendezvény kezdete: 2005.06.26.Rendezvény vége: 2005.07.01. Munkahely neve: Congrex Sweden AB Címe: Karlavägen 108 P.O. Box 5619 SE-114 86 Stockholm, Sweden Tel: +46-8-459 66 00 Fax: +46-8-661 91 25 E-mail: wac2005@congrex.se Helyszín: Munich Integrated basic and clinical themes will include current topics in immunology as well as mechanisms, prevention, diagnostics and treatment of diseases like asthma, rhinoconjunctivitis, sinusitis, atopic eczema, urticaria, drug reactions, contact dermatitis, anaphylaxis, autoimmune diseases and immunodeficiency , both in adults and children. For more information click on the website: www.congrex.com/wac2005
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment